|
1
|
Bonkat G, Bartoletti R, Bruyère F, Cai T,
Geerlings SE, Köves B, Schubert S, Wagenlehner F, Mezei T, Pilatz
A, et al: EAU Guidelines on Urological Infections. EAU Guidelines
Office, Arnhem, pp13, 2020.
|
|
2
|
Thompson A, Adamson A, Bahl A, Borwell J,
Dodds D, Heath C, Huddart R, McMenemin R, Patel P, Peters J and
Payne H: Guidelines for the diagnosis, prevention and management of
chemical- and radiation-induced cystitis. J Clin Urol. 7:25–35.
2014.
|
|
3
|
Frassetto LA, Breyer BN, Kim ED, Goluboff
ET, Leslie SW, Sant GR and Talavera F: Nonbacterial and
noninfectious cystitis. Available from: https://emedicine.medscape.com/article/2056602-overview.
Accessed May 30 2020.
|
|
4
|
Haldar S, Dru C and Bhowmick NA:
Mechanisms of hemorrhagic cystitis. Am J Clin Exp Urol. 2:199–208.
2014.PubMed/NCBI
|
|
5
|
Mukhtar S and Woodhouse C: The management
of cyclophosphamide-induced haematuria. BJU Int. 105:908–912.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Korkmaz A, Topal T and Oter S:
Pathophysiological aspects of cyclophosphamide and ifosfamide
induced hemorrhagic cystitis; implication of reactive oxygen and
nitrogen species as well as PARP activation. Cell Biol Toxicol.
23:303–312. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Crawford ML, Waller PC and Wood SM: Severe
cystitis associated with tiaprofenic acid. Br J Urol. 79:578–584.
1997.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Addiction Center: Ketamine addiction and
abuse. Available from: https://www.addictioncenter.com/drugs/hallucinogens/ketamine/.
Accessed May 30, 2020.
|
|
9
|
Manikandan R, Kumar S and Dorairajan LN:
Hemorrhagic cystitis: A challenge to the urologist. Indian J Urol.
26:159–166. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Choong SK, Walkden M and Kirby R: The
management of intractable haematuria. BJU Int. 86:951–959.
2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Emadi A, Jones RJ and Brodsky RA:
Cyclophosphamide and cancer: Golden anniversary. Nat Rev Clin
Oncol. 6:638–647. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lamm D, Persad R, Colombel M and Brausi M:
Maintenance bacillus Calmette-Guérin: The standard of care for the
prophylaxis and management of intermediate- and high-risk
non-muscle-invasive bladder cancer. Eur Urol Suppl. 9:715–734.
2010.
|
|
13
|
Hall MC, Chang SS, Dalbagni G, Pruthi RS,
Seigne JD, Skinner EC, Wolf JS Jr and Schellhammer PF: Guideline
for the management of nonmuscle invasive bladder cancer (stages Ta,
T1, and Tis): 2007 update. J Urol. 178:2314–2330. 2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Buchbinder R, Forbes A, Kobben F, Boyd I,
Snow RM and McNeil JJ: Clinical features of tiaprofenic acid
(surgam) associated cystitis and a study of risk factors for its
development. J Clin Epidemiol. 53:1013–1019. 2000.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Folland DS, Kimbrough RD, Cline RE,
Swiggart RC and Schaffner W: Acute hemorrhagic cystitis: Industrial
exposure to the pesticide chlordimeform. JAMA. 239:1052–1055.
1978.PubMed/NCBI View Article : Google Scholar
|
|
16
|
National Cancer Institute: Cancer stat
facts: Bladder cancer. Available from: www.seer.cancer.gov/statfacts/html/urinb.html.
Accessed May 30, 2020.
|
|
17
|
Lee YK, Jhang JF and Kuo HC: Clinical
outcome of augmentation enterocystoplasty for patients with
ketamine-induced cystitis. Pain Physician. 20:E431–E436.
2017.PubMed/NCBI
|
|
18
|
Martin-Suarez I, D'Cruz D, Mansoor M,
Fernandes AP, Khamashta MA and Hughes GR: Immunosuppressive
treatment in severe connective tissue diseases: Effects of low dose
intravenous cyclophosphamide. Ann Rheum Dis. 56:481–487.
1997.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kawabe Y, Eguchi K, Tsuboi M, Kita M,
Tsukada T, Takashima H, Mizokami A, Kawakami A, Matsuoka N, Migita
K and Nagataki S: Untoward effects of low dose methotrexate therapy
in rheumatoid arthritis. Ryumachi. 36:514–521. 1996.PubMed/NCBI(In Japanese).
|
|
20
|
Juszczak K, Kaszuba-Zwoińska J, Chorobik
P, Ziomber A and Thor PJ: The effect of hyperosmolar stimuli and
cyclophosphamide on the culture of normal rat urothelial cells in
vitro. Cell Mol Biol Lett. 17:196–205. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zupancic D, Jezernik K and Vidmar G:
Effect of melatonin on apoptosis, proliferation and differentiation
of urothelial cells after cyclophosphamide treatment. J Pineal Res.
44:299–306. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Babjuk M, Oosterlinck W, Sylvester R,
Kaasinen E, Böhle A, Palou-Redorta J and Rouprêt M: European
Association of Urology (EAU). EAU guidelines on non-muscle-invasive
urothelial carcinoma of the bladder, the 2011 update. Eur Urol.
59:997–1008. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Brausi M, Witjes JA, Lamm D, Persad R,
Palou J, Colombel M, Buckley R, Soloway M, Akaza H and Böhle A: A
review of current guidelines and best practice recommendations for
the management of nonmuscle invasive bladder cancer by the
international bladder cancer group. J Urol. 186:2158–2167.
2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bassi PF, Costantini E, Foley S and Palea
S: Glycosaminoglycan therapy for bladder diseases: Emerging new
treatments. Eur Urol Suppl. 10:451–459. 2011.
|
|
25
|
Lazzeri M and Montorsi F: The therapeutic
challenge of ‘chronic cystitis’: Search well, work together, and
gain results. Eur Urol. 60:78–80. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Brausi M, Oddens J, Sylvester R, Bono A,
van de Beek C, van Andel G, Gontero P, Turkeri L, Marreaud S,
Collette S and Oosterlinck W: Side effects of Bacillus
Calmette-Guérin (BCG) in the treatment of intermediate- and
high-risk Ta, T1 papillary carcinoma of the bladder: Results of the
EORTC genito-urinary cancers group randomised phase 3 study
comparing one-third dose with full dose and 1 year with 3 years of
maintenance BCG. Eur Urol. 65:69–76. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mitomycin Side Effects. Available from:
https://www.drugs.com/sfx/mitomycin-side-effects.html.
Accessed May 30, 2020.
|
|
28
|
Filson CP, Montgomery JS, Dailey SM,
Crossley HS, Lentz H, Tallman CT, He C and Weizer AZ: Complications
associated with single-dose, perioperative mitomycin-C for patients
undergoing bladder tumor resection. Urol Oncol. 32:40.e1–e8.
2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Solsona E, Iborra I, Ricós JV, Monrós JL,
Casanova J and Dumont R: Effectiveness of a single immediate
mitomycin C instillation in patients with low risk superficial
bladder cancer: Short and long-term followup. J Urol.
161:1120–1123. 1999.PubMed/NCBI
|
|
30
|
Jansen KL: A review of the nonmedical use
of ketamine: Use, users and consequences. J Psychoactive Drugs.
32:419–433. 2000.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shahani R, Streutker C, Dickson B and
Stewart RJ: Ketamine- associated ulcerative cystitis: A new
clinical entity. Urology. 69:810–812. 2007.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Meng E, Wu ST, Cha TL, Sun GH, Yu DS and
Chang SY: A murderer of young bladders: Ketamine-associated
cystitis. Urol Sci. 24:113–116. 2013.
|
|
33
|
Chen WC, Lee MH, Lee SP, Chen YL, Wu HC,
Lin HM and Liou WB: The patients with ketamine-induced cystitis
(KIC) have more severe lower urinary tract symptoms and smaller
bladder capacity than patients with interstitial cystitis/bladder
painful syndrome (IC/BPS). Neurourol Urodyn. 31:1005–1006.
2012.
|
|
34
|
Kim SJ, Koh DH, Park JS, Ahn HS, Choi JB
and Kim YS: Hemorrhagic cystitis due to intravesical instillation
of gentian violet completely recovered with conservative therapy.
Yonsei Med J. 44:163–165. 2003.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Magee P: Antiseptic drugs and
disinfectants. In: Side Effects of Drugs Annual. 1st edition. Vol
23. Aronson JK (ed). Elsevier Science, Amsterrntam, pp247-249,
2000.
|
|
36
|
Petca RC, Mareș C, Petca A, Negoiță S,
Popescu RI, Boț M, Barabás E and Chibelean CB: Spectrum and
antibiotic resistance of uropathogens in Romanian females.
Antibiotics (Basel). 9(472)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Trotman J, Nivison-Smith I and Dodds A:
Haemorrhagic cystitis: Incidence and risk factors in a transplant
population using hyperhydration. Bone Marrow Transplant.
23:797–801. 1999.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Droller MJ, Saral R and Santos G:
Prevention of cyclophosphamide-induced hemorrhagic cystitis.
Urology. 20:256–258. 1982.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Jepson RG, Williams G and Craig JC:
Cranberries for preventing urinary tract infections. Cochrane
Database Syst Rev. 10(CD001321)2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Das S: Natural therapeutics for urinary
tract infections-a review. Futur J Pharm Sci. 6(64)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Sihra N, Goodman A, Zakri R, Sahai A and
Malde S: Nonantibiotic prevention and management of recurrent
urinary tract infection. Nat Rev Urol. 15:750–776. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Cowan CC, Hutchison C, Cole T, Barry SJ,
Paul J, Reed NS and Russell JM: A randomised double-blind
placebo-controlled trial to determine the effect of cranberry juice
on decreasing the incidence of urinary symptoms and urinary tract
infections in patients undergoing radiotherapy for cancer of the
bladder or cervix. Clin Oncol (R Coll Radiol). 24:e31–e38.
2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Campbell G, Pickles T and D'yachkova Y: A
randomised trial of cranberry versus apple juice in the management
of urinary symptoms during external beam radiation therapy for
prostate cancer. Clin Oncol (R Coll Radiol). 15:322–328.
2003.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Hamilton K, Bennett NC, Purdie G and Herst
PM: Standardized cranberry capsules for radiation cystitis in
prostate cancer patients in New Zealand: A randomized double
blinded, placebo controlled pilot study. Support Care Cancer.
23:95–102. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Herst PM, Aumata A, Sword V, Jones R,
Purdie G and Costello S: Cranberry capsules are not superior to
placebo capsules in managing acute non-haemorrhagic radiation
cystitis in prostate cancer patients: A phase III double blinded
randomised placebo controlled clinical trial. Radiother Oncol.
149:117–123. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Turkeri LN, Lum LG, Uberti JP, Abella E,
Momin F, Karanes C, Sensenbrenner LL and Haas GP: Prevention of
hemorrhagic cystitis following allogeneic bone marrow transplant
preparative regimens with cyclophosphamide and busulfan: Role of
continuous bladder irrigation. J Urol. 153:637–640. 1995.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hensley ML, Hagerty KL, Kewalramani T,
Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar
WJ, Mitchell RB, et al: American society of clinical oncology 2008
clinical practice guideline update: Use of chemotherapy and
radiation therapy protectants. J Clin Oncol. 27:127–145.
2009.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ballen KK, Becker P, Levebvre K, Emmons R,
Lee K, Levy W, Stewart FM, Quesenberry P and Lowry P: Safety and
cost of hyperhydration for the prevention of hemorrhagic cystitis
in bone marrow transplant recipients. Oncology. 57:287–292.
1999.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Vose JM, Reed EC, Pippert GC, Anderson JR,
Bierman PJ, Kessinger A, Spinolo J and Armitage JO: Mesna compared
with continuous bladder irrigation as uroprotection during
high-dose chemotherapy and transplantation: A randomized trial. J
Clin Oncol. 11:1306–1310. 1993.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Tiglis M, Neagu TP, Elfara M, Diaconu CC,
Bratu OG, Vacaroiu IA and Grintescu IM: Nefopam and its role in
modulating acute and chronic pain. Rev Chim (Bucharest).
69:2877–2880. 2018.
|
|
51
|
Petca RC, Popescu RI, Mehedintu C, Bot M,
Veduta A and Petca A: The role of ultrasound in diagnosis and
management in renal colic during . In: Proceedings of the 6th
Congress of the Ultrasound Society in Obstetrics and
Gynecology/34th Fetus as a Patient International Congress.
Bucharest, pp478-484, 2018.
|
|
52
|
Diaconu CC: Midaortic syndrome in a young
man: Case presentation. Cor Vasa. 59:e171–e173. 2017.
|
|
53
|
Moharamzadeh P, Ojaghihaghighi S, Amjadi
M, Rahmani F and Farjamnia A: Effect of tranexamic acid on gross
hematuria: A pilot randomized clinical trial study. Am J Emerg Med.
35:1922–1925. 2017.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Decker DB, Karam JA and Wilcox DT:
Pediatric hemorrhagic cystitis. J Pediatr Urol. 5:254–264.
2009.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Westerman ME, Boorjian SA and Linder BJ:
Safety and efficacy of intravesical alum for intractable
hemorrhagic cystitis: A contemporary evaluation. Int Braz J Urol.
42:1144–1149. 2016.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Ho CC and Md Zainuddin Z: Alum irrigation
for the treatment of intractable haematuria. Malays J Med Sci.
16:66–68. 2009.PubMed/NCBI
|
|
57
|
Dewan AK, Mohan GM and Ravi R:
Intravesical formalin for hemorrhagic cystitis following
irradiation of cancer of the cervix. Int J Gynaecol Obstet.
42:131–135. 1993.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Vicente J, Rios G and Caffaratti J:
Intravesical formalin for the treatment of massive hemorrhagic
cystitis: Retrospective review of 25 cases. Eur Urol. 18:204–206.
1990.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Ricciotti E and FitzGerald GA:
Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol.
31:986–1000. 2011.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Demir HA, Savaş Şen Z, Altuğ MU, Emir S
and Tunç B: Successful treatment of cyclophosphamide-induced
haemorrhagic cystitis with intravesical prostaglandin E1 in a child
with non-Hodgkin's lymphoma. Scand J Urol Nephrol. 45:281–284.
2011.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Yamamoto M, Hibi H, Ohmura M and Miyake K:
Successful treatment of hemorrhagic cystitis secondary to
cyclophosphamide chemotherapy with intravesical instillation of
prostaglandin F2 alpha. Hinyokika Kiyo. 40:833–835. 1994.PubMed/NCBI
|
|
62
|
Ippoliti C, Przepiorka D, Mehra R, Neumann
J, Wood J, Claxton D, Gajewski J, Khouri I, van Besien K, Andersson
B, et al: Intravesicular carboprost for the treatment of
hemorrhagic cystitis after marrow transplantation. Urology.
46:811–815. 1995.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Sommariva ML, Sandri SD and Ceriani V:
Efficacy of sodium hyaluronate in the management of chemical and
radiation cystitis. Minerva Urol Nefrol. 62:145–150.
2010.PubMed/NCBI
|
|
64
|
Imperatore V, Creta M, Di Meo S, Buonopane
R, Longo N, Fusco F, Spirito L, Imbimbo C and Mirone V:
Intravesical administration of combined hyaluronic acid and
chondroitin sulfate can improve symptoms in patients with
refractory bacillus Calmette-Guerin-induced chemical cystitis:
Preliminary experience with one-year follow-up. Arch Ital Urol
Androl. 90:11–14. 2018.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Davis M, MacDonald H, Sames C and Nand K:
Severe cyclophosphamide-induced haemorrhagic cystitis treated with
hyperbaric oxygen. N Z Med J. 124:48–54. 2011.PubMed/NCBI
|
|
66
|
Ajith Kumar S, Prasanth P, Tripathi K and
Ghosh P: Hyperbaric oxygen-a new horizon in treating
cyclophosphamide-induced hemorrhagic cystitis. Indian J Urol.
27:272–273. 2011.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Duthie G, Whyte L, Chandran H, Lawson S,
Velangi M and McCarthy L: Introduction of sodium pentosan
polysulfate and avoidance of urethral catheterisation: Improved
outcomes in children with haemorrhagic cystitis post stem cell
transplant/chemotherapy. J Pediatr Surg. 47:375–379.
2012.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Abt D, Bywater M, Engeler DS and Schmid
HP: Therapeutic options for intractable hematuria in advanced
bladder cancer. Int J Urol. 20:651–660. 2013.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Stefanini M, English HA and Taylor AE:
Safe and effective, prolonged administration of epsilon
aminocaproic acid in bleeding from the urinary tract. J Urol.
143:559–561. 1990.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Kaye JD, Smith EA, Kirsch AJ, Cerwinka WH
and Elmore JM: Preliminary experience with epsilon aminocaproic
acid for treatment of intractable upper tract hematuria in children
with hematological disorders. J Urol. 184:1152–1157.
2010.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Liu YK, Harty JI, Steinbock GS, Holt HA
Jr, Goldstein DH and Amin M: Treatment of radiation or
cyclophosphamide induced hemorrhagic cystitis using conjugated
estrogen. J Urol. 144:41–43. 1990.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Miller J, Burfield GD and Moretti KL: Oral
conjugated estrogen therapy for treatment of hemorrhagic cystitis.
J Urol. 151:1348–1350. 1994.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Ordemann R, Naumann R, Geissler G,
Bornhauser M, Schuler U and Ehninger G: Encouraging results in the
treatment of haemorrhagic cystitis with estrogen-report of 10 cases
and review of the literature. Bone Marrow Transplant. 25:981–985.
2000.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Mousavi SA, Moazed V, Mohebbi N,
Hadjibabaie M, Alimoghaddam K, Bahar B, Jahani M and Ghavamzadeh A:
Conjugated estrogen in late-onset hemorrhagic cystitis associated
with hematopoietic stem cell transplantation. Int J Hematol Oncol
Stem Cell Res. 11:13–18. 2017.PubMed/NCBI
|
|
75
|
Geisler JP, Linnemeier GC and Manahan KJ:
Recombinant factor VIIa to treat late radiation-induced hemorrhagic
cystitis: A case report. J Reprod Med. 53:360–362. 2008.PubMed/NCBI
|
|
76
|
Ashrani AA, Gabriel DA, Gajewski JL,
Jacobs DR Jr, Weisdorf DJ and Key NS: Pilot study to test the
efficacy and safety of activated recombinant factor VII (NovoSeven)
in the treatment of refractory hemorrhagic cystitis following
high-dose chemotherapy. Bone Marrow Transplant. 38:825–828.
2006.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Karimi M, Zakerinia M, Khojasteh HN, Ramzi
M and Ahmad E: Successful treatment of cyclophosphamide induced
intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven)
after allogenic bone marrow transplantation. J Thromb Haemost.
2:1853–1855. 2004.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Pihusch M, Bacigalupo A, Szer J, von Depka
Prondzinski M, Gaspar-Blaudschun B, Hyveled L and Brenner B:
F7BMT-1360 Trial Investigators. Recombinant activated factor VII in
treatment of bleeding complications following hematopoietic stem
cell transplantation. J Thromb Haemost. 3:1935–1944.
2005.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Lai HH, Shen B, Vijairania P, Zhang X,
Vogt SK and Gereau RW IV: Anti-vascular endothelial growth factor
treatment decreases bladder pain in cyclophosphamide cystitis: A
multidisciplinary approach to the study of chronic pelvic pain
(MAPP) research network animal model study. BJU Int. 120:576–583.
2017.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Tanik S, Zengin K, Albayrak S, Gurel A,
Atar M, Sahin S, Tuzcu N, Tuzcu M, Imamoglu MA and Gurdal M:
Assessment of therapeutic effect of human choriogonadotropin in a
chemical cystitis model. Kaohsiung J Med Sci. 33:229–235.
2017.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Acar D, Cayan S, Aktaş S, Tek M and Akbay
E: The effect of tamoxifen on bladder functions and histology, and
the role of estrogen receptor beta in a rat chemical cystitis
model. Neurourol Urodyn. 26:309–316. 2007.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Ozyuvali E, Yildirim ME, Yaman T, Kosem B,
Atli O and Cimentepe E: Protective effect of intravesical
platelet-rich plasma on cyclophosphamide-induced hemorrhagic
cystitis. Clin Invest Med. 39(27514)2016.PubMed/NCBI
|
|
83
|
Jiang YH, Liao CH and Kuo HC: Current and
potential urological applications of botulinum toxin A. Nat Rev
Urol. 12:519–533. 2015.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Chibelean CB, Nechifor-Boilă IA, Petca RC,
Balan D, Martha O, Petca A and Dogaroiu C: Abobotulinumtoxin A in
idiopathic hyperactive bladder-ethical issues. Rom J Leg Med.
27:213–216. 2019.
|
|
85
|
Chuang YC, Kim DK, Chiang PH and
Chancellor MB: Bladder botulinum toxin A injection can benefit
patients with radiation and chemical cystitis. BJU Int.
102:704–706. 2008.PubMed/NCBI View Article : Google Scholar
|
